Drug Trial Radar · NCT05199584
A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Last checked: Nov 19, 2026Latest source record: Mar 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
20
Actual
Start
May 24, 2022
Primary completion
Feb 20, 2024
Study completion Feb 20, 2024
Sponsor
- Lead sponsor
- Endeavor Biomedicines, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jan 20, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study employs a 2-stage design that aims to evaluate the efficacy and safety of ENV- 101, a potent Hedgehog (Hh) pathway inhibitor, in patients with refractory advanced solid tumors characterized by loss of function (LOF) mutations in the Patched-1 (PTCH1) gene. Stage 1 of this study will enroll approximately 44 patients randomized between two dose levels. As appropriate, Stage 2 of the study will expand enrollment based on the results of Stage 1.
Conditions
- Solid Tumors With PTCH1 Loss-of-function Mutations
Interventions
ENV-101 (taladegib)Drug
tablets dosed once-daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Objective Response Rate (ORR)Time frame: through study completion, an average of 6 months
Locations
16 sites in 1 country. Site status is shown where the registry gives one.
Research Site
Los Angeles, California
Research Site
Santa Rosa, California
Research Site
Tampa, Florida
Research Site
Zion, Illinois
Research Site
Covington, Louisiana
Research Site
Las Vegas, Nevada
Research Site
New York, New York
Research Site
Durham, North Carolina
Research Site
Cincinnati, Ohio
Research Site
Columbus, Ohio
Research Site
Pittsburgh, Pennsylvania
Research Site
Nashville, Tennessee
Research Site
Houston, Texas
Research Site
Fredericksburg, Virginia
Research Site
Lynchburg, Virginia
Research Site
Madison, Wisconsin
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.